Alk Actionable Mutations (Muts) Within Cancer Types And Their Responses To Crizotinib (Cz).

Lin Li,Caixia Liu,Jun Zhao,Lin Gen,Xiaorong Dong,Fenglei Yu,Xinghao Ai,Dongning Huang,Likun Chen,Xiangyang Cheng,Jinliang Kong,Renhua Guo,Liyun Miao,Li Lin,Li Liu,Gui Huang,Qiaoli Wang,Rongrong Chen,Xuefeng Xia

JOURNAL OF CLINICAL ONCOLOGY（2019）

引用 0|浏览35

暂无评分

摘要

e14739Background: CZ was recommended by NCCN for ALK-rearranged metastasis NSCLC as first-line therapy. Knowledge on the occurrence of ALK actionable muts within cancer types and the responses of A...

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要